Neelesh Tiwari

Neelesh Tiwari

Active Director Director DIN 02042706
DIN 02042706 First appointment Oct 2008 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 6 active board seats
Past companies 8 historical roles
Total affiliations 14 Since Oct 2008
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 31 Oct 2008
Active appointments 10
Total timeline records 14

Neelesh Tiwari (DIN 02042706) has 14 recorded board appointments in Indian companies, the first from October 2008, of which 10 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2008
Super Sun Consulting Private Limited Director · 2025 – present
Current
Trisun Exim Tradex Private Limited Director · 2025 – present
Current
Algometrics Investment Private Limited Director · 2024 – present
Current
Royal House Of Psychiatry Private Limited Director · 2023 – present
Current
Bounce Back Global Health Private Limited Director · 2022 – present
Current
Gaddiel Innovations Private Limited Director · 2016 – present
Current
Soulgate Education Private Limited Director · 2016 – present
Current
Holy Herbs Private Limited Director · 2013 – present
Current
Mera Pharma Dot Com Private Limited Director · 2009 – present
Current
World Brain Center And Research Institute Director · 2008 – present
Current
Gaddiel Industries Private Limited Additional Director · 2020 – 2022
Previous
Previous
Alexis Energy Solutions Private Limited Director · 2011 – 2014
Previous
Dorris Pharmaceuticals Private Limited Director · 2009 – 2016
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available